ProQR Therapeutics
PRQR
PRQR
57 hedge funds and large institutions have $364M invested in ProQR Therapeutics in 2018 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
57
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$53.7M | |
| 2 | +$45M | |
| 3 | +$11.1M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$7.89M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.58M |
Top Sellers
| 1 | -$51.9M | |
| 2 | -$28.1M | |
| 3 | -$9.47M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.13M |
| 5 |
Morgan Stanley
New York
|
-$1.46M |